Introduction

Bacteroidota (formerly known as Bacteroidetes) represents one of the most dominant and functionally significant phyla within the human gut ecosystem. These Gram-negative bacteria are essential for maintaining microbial balance and supporting the host's metabolic and immunological health. Through complex host-microbe interactions, Bacteroidota help the body break down complex carbohydrates and modulate inflammatory signaling, making them a cornerstone of a healthy gut microbiome.

Location of Microbe

Primary Ecosystem: Gut

Bacteroidota are primarily located in the human gastrointestinal tract, where they are among the most abundant taxa. They reside predominantly in the colon, often forming a significant portion of the total microbial load in both adults and infants, as well as in first-pass meconium in newborn infants.

Behavior During Dysbiosis

Microbial Shifts

During states of dysbiosis, the abundance of Bacteroidota often fluctuates significantly. In some conditions, such as certain types of cancer or systemic inflammation, there is a notable reduction in Bacteroidota levels. Conversely, in other dysbiotic states—such as obesity-related patterns or specific inflammatory conditions—Bacteroidota taxa may actually increase, potentially shifting the gut ecosystem toward a more mucolytic and pro-inflammatory state.

Disease Associations

Metabolic and Cognitive Health

Bacteroidota abundance is closely associated with metabolic markers. In obese individuals, an enrichment of specific Bacteroidota taxa, including Parabacteroides and Bacteroides, is observed, which may relate to alterations in carbohydrate metabolism, succinate, and bile acid processing. Furthermore, shifts in the abundance of Bacteroidota-associated taxa have been linked to cognitive decline in older adults, suggesting a connection via the gut-brain axis.

Autoimmune and Inflammatory Conditions

Dysbiosis involving this phylum is associated with various autoimmune disorders. In patients with active spreading vitiligo, the gut microbiome is often dominated by an imbalanced proportion of Bacteroidota and Actinomycetota. Additionally, a reduction in Bacteroidota is associated with patients suffering from acute lung injury (ALI) after cardiopulmonary bypass, indicating a potential role in the gut-lung axis of systemic inflammation.

Oncology and Other Systemic Links

Bacteroidota levels are often altered in cancer patients; for instance, breast cancer patients have been found to exhibit lower levels of this phylum compared to the general population. In the context of cancer immunotherapy, a higher relative abundance of SCFA-producing bacteria, including those within the Bacteroidota phylum, is associated with improved objective response rates to immune checkpoint inhibitors (ICIs).

Foods Supporting Healthy Balance

Maintaining a balanced abundance of Bacteroidota is primarily achieved through the consumption of high-fiber diets and specific bioactive compounds. Dietary fibers, starches, and plant polysaccharides are known to increase the Bacteroidota/Bacillota ratio, promoting a more desirable phenotype associated with lean metabolic profiles. Specifically, tomato consumption has been shown to help prevent the decrease of Bacteroidota and maintain a higher ratio relative to Bacillota, likely due to the presence of small-molecule phytochemicals.

Additionally, curcumin supplementation in older adults with prediabetes has demonstrated a marginal enrichment of beneficial Bacteroidota, including the Bacteroidaceae family and the genus Bacteroides. The integration of prebiotic fibers and a high-quality diet (rich in fruits, vegetables, and whole grains) is associated with greater microbial diversity and protects against the depletion of fiber-responsive taxa, thereby supporting long-term gut barrier integrity and metabolic stability.

Actionable Insights

• Prioritize Complex Fibers: Increase intake of whole grains, legumes, and vegetables to support the growth of fiber-fermenting Bacteroidota and enhance the production of short-chain fatty acids (SCFAs).
• Incorporate Phytochemicals: Regular consumption of tomatoes and other berry-rich foods (containing anthocyanins) may help maintain a healthy Bacteroidota/Bacillota ratio and support cognitive health in aging populations.
• Consider Targeted Supplementation: For those with prediabetes or metabolic concerns, curated supplements like curcumin may modestly support the enrichment of beneficial Bacteroides species.
• Monitor Dietary Quality during Medical Treatment: Patients undergoing chemotherapy should focus on maintaining high diet quality (HEI scores) to prevent the loss of key fiber-responsive taxa and preserve microbial diversity.
• Personalize Nutrition based on Enterotype: Be aware that responses to dietary interventions, such as anthocyanins, vary based on your baseline enterotype (e.g., Bacteroides-dominant types), underscoring the need for personalized microbiome-informed nutrition.

Conclusion

Bacteroidota plays a fundamental role in the gut ecosystem, acting as a primary driver of carbohydrate metabolism and immune modulation. While often viewed as beneficial commensals, their impact is highly context-dependent, where both excessive enrichment and significant depletion are associated with various states of dysbiosis—ranging from obesity and autoimmune diseases to cognitive decline. By leveraging dietary interventions such as high fiber intake and targeted phytochemicals, it is possible to support a balanced Bacteroidota population, which in turn promotes gut barrier integrity and overall systemic health.